Ethnicity and peripheral artery disease

QJM: An International Journal of Medicine

Volumn 102, Issue 1, 2009, Pages 3-16

  Bennett, P C ^a,b   Silverman, S ^b   Gill, P S ^c   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN A;

AFRICAN CARIBBEAN; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; BANGLADESH; BUERGER DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMIGRANT; IMPAIRED GLUCOSE TOLERANCE; INDIA; INFLAMMATION; KIDNEY ARTERY STENOSIS; LIMB AMPUTATION; METABOLIC SYNDROME X; NEGRO; PAKISTAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SOUTH ASIA; THROMBOGENESIS; UNITED KINGDOM;

EID: 58149092777     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn140     Document Type: Review

References (166)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; on behalf of the TASC 11 working group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33:S1-75.
2. CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348:1329-39.
3. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes GR, Isselbacher EM, McCullough PA, et al. Atherosclerosis vascular disease conference: writing group i: Epidemiology. Circulation 2004; 109:2605-12.
4. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006; 114:688-99.
5. Criqui MH, Denenberg JO. The generalised nature of atherosclerosis: How peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998; 3:241-5.
6. Dormandy J, Heeck L, Vig S. Lower extremity arteriosclerosis as a reflection of a systemic process: Implications for concomitant coronary and carotid disease. Semin Vasc Surg 1999; 12:118-22.
7. Newman AB, Sutto-Tyrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993; 270:487-9.
8. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10years in patients with peripheral arterial disease. NEJM 1992; 326:381-6.
9. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of aymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20:384-92.
10. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18:185-92.
11. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis 2004; 172:95-105.
12. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: A critical review. Am J Med 2002; 112:49-57.
13. Premalatha G, Markovitz J, Shanthirani S, Mohan V, Deepa R. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population. Diabetes care 2000; 23:1295-300.
14. Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, et al Ethnicity and peripheral arterial disease: The San Diego Population Study. Circulation 2005; 112:2703-7.
15. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Paper XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 1994; 11:670-7.
16. Mohan V, Premalatha G, Sastry NG. Peripheral vascular disease in non-insulin-dependent diabetes mellitus in south India. Diabetes Res Clin Pract 1995; 27:235-40.
17. Chaturvedi N, Coady E, Mayet J, Wright AR, Shore AC, Byrd S, et al Indian Asian men have less peripheral arterial disease than European men for equivalent levels of coronary disease. Atherosclerosis 2007; 193:204-12.
18. Collins TE, Petersen NJ, Suarez-Almazor M, Ashton CM. Ethnicity and peripheral arterial disease. Mayo Clin Proc 2005; 80:48-54.
19. McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, et al. Ankle-Brachial Index and subclinical cardiac and carotid disease. The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2005; 162 33-41.
20. Fabsitz RR, Sidaway AN, Go O, Lee ET, Welty TK, Devereux RB, et al Prevalence of Peripheral Arterial Disease and Associated Risk Factors in American Indians: The Strong Heart Study. Am J Epidemiol 1999; 149:330-8.
21. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110:738-43.
22. Allison MA, Criqui MH, McClelland RL, Scott JM, McDermott MM, Liu K, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Mulyi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48 1190-7.
23. He Y, Jiang Y, Wang J, Fan L, Li X, Hu FB. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006; 44:333-8.
24. Al-Sheikh SO, Aljabri BA, Al-Ansary LA, Al-Khayal LA, Al-Salman MM, Al-Omran MA. Prevalence of and risk factors for peripheral arterial disease in Saudi Arabia. A pilot cross-sectional study. Saudi Med J 2007; 28:412-4.
25. Garfolo L, Barros N, Miranda F, D'Almeida V, Cardien LC, Ferreira SR. Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian Population. Eur J Vasc Endovasc Surg 2007; 34:23-8.
26. Sritara P, Sritara C, Woodward M, Wangsuphachart S, Barzi F, Hengprasith B, et al. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology 2007; 58 572-8.
27. Carbayo JA, Divisón JA, Escribano J, López-Abril J, López de Coca E, Artigao LM, et al. Using ankle-brachial index to detect peripheral arterial disease: Prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis 2007; 17 41-9.
28. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45:1185-91.
29. Kumar A, Mash B, Rupesinghe G. Peripheral arterial disease - high prevalence in rural black South Africans. S Afr Med J 2007; 97 285-8.
30. Gill PS, Kai J, Bhopal RS, Wild S. Health care needs assessment: Black and minority ethnic groups. In: Stevens A, Raferty J, Mant JM, eds. Health Care Needs Assessment. The Epidemiologically Based Needs Assessment Reviews. Third series. Oxford, Radcliffe Medical Press, 2007.
31. National Statistics Online. [http://www.statistics.gov.uk/cci/ nugget.asp?id=273] (17 October 2008, date last accessed).
32. Makin A, Silverman S, Lip GYH. Ethnic differences in peripheral vascular disease. IJCP 2002; 56:605-8.
33. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 2001; 286:1599-606.
34. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295:547-53.
35. Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: Long term follow-up of a large database. BMC Cardiovasc Disord 2005; 5:14.
36. Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease. Edinburgh Artery Study. Eur Heart J 1999; 20:344-53.
37. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26:3333-41.
38. Garcia LA. Epidemiology and pathophysiology of lower extremity peripheral artery disease. J Endovasc Ther 2006; 13 II-3-II-9.
39. Almahameed A. Peripheral arterial disease: Recognition and medical management. Cleve Clin J Med 2006; 73:621-34.
40. Dieter RS, Chu WW, Pacanowski JP, McBridge PE, Tanke TE. The significance of lower extremity peripheral arterial disease. Clin Cardiol 2002; 25:3-10.
41. Smith SC, Milani RV, Arnett DK, Crouse JR, McGrae McDermot M, Ridker PM, et al. Atherosclerosis Vascular Disease Conference: Writing Group II: Risk Factors. Circulation 2004; 109:2613-6.
42. Khawaja FJ, Bailey KR, Turner ST, Kardia SL, Mosley TH, Kullo IJ. Association of novel risk factors with the ankle brachial index in African American and Non-Hispanic White populations. Mayo Clin Proc 2007; 82:709-16.
43. Cheng SW, Ting AC, Wong J. Lipoprotein(a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. Eur J Vasc Endovasc Surg 1997; 14:17-23.
44. Tseng CH. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan. Diabetes Care 2004; 27:517-21.
45. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991; 302:560-4.
46. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KGMM, et al Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi and European origin populations: Cross-sectional study. Br Med J 1999; 319:215-20.
47. Fowkes FGR, Housley E, Riemersma RA, Macintyre CCA, Cawood EHH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992; 135:331-40.
48. Heliovaara M, Karvonen MJ, Vilhunen R, Punsar S. Smoking, carbon monoxide and atherosclerotic diseases. Br Med J 1978; 1 268-70.
49. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1 333-9.
50. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138:891-8.
51. Willigendael EM, Teijink JA, Bartelink ML, Boiten J, Moll FL, Buller HR, et al. Influence of smoking on incidence and prevalence of PAD. J Vasc Surg 2004; 40:1158-65.
52. Fowler B, Jamrozki K, Norman P, Allen Y. Prevalence of peripheral artery disease: Persistence of excess risk in former smokers. Aust NZ J Public Health 2002; 26:219-24.
53. Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand 1988; 154:635-40.
54. Lepantalo M, Lassila R. Smoking and occlusive peripheral arterial disease: Clinical review. Eur L Surg 1991; 157:83-7.
55. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication: Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Ned Scand 1987; 221:253-60.
56. Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 2005; 20:474-8.
57. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart 2003; 89:681-6.
58. Lane DA, Lip GYH, Beevers G. Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: The Birmingham Factory Screening Project. J Hypertens 2005; 23:1347-53.
59. Collins TC, Petersen NJ, Suarez-Almazor M, Ashton CM. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med 2003; 163:1469-74.
60. Kuller L, Fisher L, McClelland R, Fried L, Cushman M, Jackson S, et al. Differences in prevalence of and risk factors for subclinical vascular disease among Black and White participants in the cardiovascular health study. Arterioscler Thromb Vasc Biol 1998; 18:283-93.
61. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences and medical therapy: Part II. Circulation 2003; 108:1655-61.
62. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993; 88:837-45.
63. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part 1. Circulation 2003; 108:1527-32.
64. Selvin E, Coresh J, Wattanakit K, Sharrett AR, Steffes MW. HbA1c and peripheral artery disease in diabetes. Diabetes Care 2006; 29 877-82.
65. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:854-65.
66. Murabito JM, D'Agostino RB, Silberhatz H, Wilson WF. Intermittent claudication: A risk profile from the Framingham Heart Study. Circulation 1997; 96:44-9.
67. Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes Int 1999; 16:163-6.
68. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Craeger MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286:1317-24.
69. Health Survey for England 2004: The health of Minority Ethnic Groups- headline tables. ©2005. NHS Health and Social Care Information Centre, Public Health Statistics. All rights reserved.
70. Chaturvedi N, McKeigue PM, Marmot MG. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 1994; 37:765-72.
71. Diabetes in the UK 2004. A report from Diabetes UK, October 2004. http://www.diabetes.org.uk.
72. Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M. Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care 1992; 15 1348-55.
73. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 345:405-9.
74. Patel J, Vyas A, Cruickshank JK, Phrabharkaran D, Hughes EA, Mackness MI, et al. Impact on migration on coronary heart disease risk factors: Comparison of Gujratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis 2006; 185 297-306.
75. Beach KW, Bedford GR, Bergelin RO, Martin DC, Vandenberghe N, Zaccardi M, et al. Progression of lower-extremity arterial occlusive disease in type 2 diabetes mellitus. Diabetes Care 1998; 11 464-72.
76. Abbot CA, Morris JM, Garrow AP, Van Ross ER, Carrington AL, Boulton AJ. Foot ulcer risk is lower in South Asian and African Caribbean patients in the UK. The North-West Diabetes Foot Care Study. Diabetes Care 2005; 8:1869-75.
77. Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M. Risk factors, ethnic differences and mortality associated with lower extremity gangrene and amputation in diabetes: The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44(Suppl. 2):S65-S71 (B).
78. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, et al Atherosclerotis Vascular Disease Conference: Writing Group III: Pathophysiology. Circulation 2004; 109:2617-25.
79. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285 2481-5.
80. Health Survey for England- The health of Minority Ethnic Groups 1999. [http://www.archive.official-documents.co.uk/document/doh/survey99/ hse99-04.htm] (17 October 2008, date last accessed).
81. Miller G, Becles GLA, Byam NT, Price SG, Carson DC, Kirkwood BR, et al. Serum lipoproteins concentration in relation to ethnic composition and urbanisation in men and women of Trinidad West Indies. Int J Epidemiol 1984; 13:413-21.
82. Li ZY, Xu GB, Xia TA. Prevalence rate of metabolic syndrome and dyslipidaemias in large professional population in Beijing. Atherosclerosis 2006; 184:188-92.
83. Zoratti R. A review on ethnic differences in plasma triglycerides and high density lipoprotein cholesterol: Is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin. Eur J Epidemiol 1998; 14:9-21.
84. Whincup PH, Gilg JA, Papcosta O, Seymour C, Miller GJ, Alberti KGMM, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. Br Med J 2002; 324:1-6.
85. Lip GYH, Barnett AH, Bradbury A, Cappuccio FP, Gill PS, Hughes E, et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: A practical approach to management. J Hum Hypertens 2007; 21:183-211.
86. Keenen JP, Robbs JV. Lipid profiles in peripheral vascular disease: A comparison between blacks and whites. S Afr J Surg 1985; 23 15-7.
87. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-9.
88. Cheng SW, Ting AC, Lau H, Wong J. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J Surg 1999; 23:202-6.
89. Vidi F, Criqui M, Longoni A, Castiglioni C. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the ADEP study. Atherosclerosis 1996; 120:25-35.
90. Makin A, Lip GYH, Silverman S, Beevers DG. Peripheral vascular disease and hypertension: A forgotten association? J Hum Hypertens 2001; 15:447-54.
91. Palumbo PJ, O'Fallon WM, Osmundson POJ, Zimmerman BR, Langworthy AL, Kazmier FJ, et al. Progression of peripheral arterial occlusive disease in diabetes mellitus. What factors are predictive? Arch Intern Med 1991; 151:717-21.
92. Agyemang C, Bhopal R. Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectional data. J Hum Hypertens 2003; 17:523-34.
93. Brown MJ. Hypertension and ethnic group. Br Med J 2006; 332 833-6.
94. Cooper RS, Rotimi C, Ataman S, McGee D, Osotomehin B, Kadiri S, et al The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997; 87:160-8.
95. Cappuccio F, Cook D, Atkinson R, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in South London. Heart 1997; 78:555-63.
96. Primatesta P, Bost L, Poulter NR. Blood pressure levels and hypertension status among ethnic groups in England. J Hum Hypertens 2000; 14 143-8.
97. Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data. J Hum Hypertens 2002; 16:739-51.
98. Gupta R, Al-Odat NA, Gupta VP. Hypertension epidemiology in India: meta-analysis of 50 year prevalence rates and blood pressure trends. J Hum Hypertens 1996; 10:465-72.
99. Perry HM, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke. The systolic hypertension in the elderly program (SHEP). JAMA 2000; 282 465-71.
100. Dieplinger H, Utermann G. The seventh myth of lipoprotein(a): Where and how is it assembled? Curr Opin Lipidol 1999; 10:275-83.
101. Raleigh VS, Kiri V, Balarajan R. Variations in mortality from diabetes mellitus, hypertension and renal disease in England and Wales by country of birth. Health Trends 1996; 28:12-122.
102. Wild S, McKeigue P. Cross-sectional analysis of mortality by country of birth in England and Wales 1970-1992. Br Med J 1997; 314 705-10.
103. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-43.
104. Devaraj S, Xu DY, Jialal I. C-reactive protein increases Plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis. Circulation 2003; 107:398-404.
105. Brevetti G, Schiano V, Sirico G, Giugliano G, Laurenzano E, Chiariello M. Metabolic syndrome in peripheral arterial disease: Relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. J Vasc Surg 2006; 44:101-7.
106. Ridker PM, Cushman M, Stampfer MJ, Tracey RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425-8.
107. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112:976-83.
108. Tzoulaki I, Murray GD, Price JF, Smith FB, Lee AJ, Rumley A, et al Haemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis. The Edindurgh Artery Study. Am J Epidemiol 2006; 163:334-41.
109. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. A critical review of the evidence. JAMA 2003; 290 932-40.
110. Vidula H, Tian L, Liu K, Criqui M, Ferrucci L, Pearce W, et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study. Ann Intern Med 2008; 148:85-93.
111. Li J, Li JJ, Li Q, Li Z, Qian HY. A rational connection of inflammation with peripheral arterial disease. Med Hypotheses 2007; 69 1190-5.
112. Vainas T, Stassen FRM, De Graaf R, Twiss ELL, Herngreen SB, Welton RJTJ, et al. C-reactive protein in peripheral arterial disease: Relation to severity of the disease and to future cardiovascular events. J Vasc Surg 2005; 42:243-51.
113. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 2003; 38:374-9.
114. Wildman RP, Muntner P, Chen, Sutton-Tyrrell K, He J. Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002. Am J Cardiol 2005; 96 1579-83.
115. Kamath S, Lip GYH. Fibrinogen: Biochemistry, epidemiology and determinants. QJM 2003; 96:711-29.
116. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, et al. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. JAMA 2005; 294:1799-809.
117. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2005; 180:389-97.
118. Lip GYH, Blann AD, Edmunds E, Beevers DG. Baseline abnormalities of endothelial function and thrombogenesis in relation to restenosis in essential hypertension. Blood Coagul Fibrinolysis 2002; 13 35-41.
119. Vene N, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulation therapy. Thromb Haemost 2003; 90 1163-72.
120. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FGR. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007; 28:354-62.
121. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, et al. Role of Lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck Study. Circulation 1949; 100:1154-60.
122. Berglund L, Ramakrishnan R. Lipoprotein(a): An elusive cardiovascular risk factor. Arterioscler Thromb, Vasc Biol 2004; 24:2219-26.
123. Utermann G. The mysteries of lipoprotein(a). Science (Washington DC 1989; 246:904-10.
124. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000; 102 1082-5.
125. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998; 47:182-4.
126. Dahlen GH, Stenlund H. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: Pathogenic mechanisms and clinical significance. Clin Genet 1997; 52:272-80.
127. Clarke R, Daly L, Robinson K. Hyperhomocysteinaemia: An independent risk factor for vascular disease. N E J Med 1999; 324:1149-55.
128. Welch GN, Loscolzo J. Homocysteine and atherosthrombosis. N Eng J Med 1998; 338:1042-5.
129. Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background. Arch Intern Med 1997; 157:2299-308.
130. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, et al. Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest 1999; 29:100-8.
131. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet and cardiovascular diseases: A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1999; 99:178-82.
132. Boushey CJ, Beresford GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274 1049-57.
133. Taylor LM Jr. Elevated plasma homocysteine as a risk factor for peripheral arterial disease: What is the evidence? Semin Vasc Surg 2003; 16:215-222.
134. Cappuccio FP, Barbato A, Kerry SM. Hypertension, diabetes and cardiovascular risk in ethnic minorities in the UK. Br J Diabetes Vasc Dis 2003; 3:286-93.
135. Chandalia M, Abate N, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM. Hyperhomocysteinaemia in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88:1089-95.
136. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. [http://www.idf.org/webdata/docs/ idf_meta_def_final.pdf] (17 October 2008, date last accessed).
137. Whitty CJ, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II Study. Atherosclerosis 1999; 142:279-86.
138. Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG. Low ankle brachial pressure index predicts increased risk of cardiovascular disease independent of metabolic syndrome and conventional cardiovascular risk factors in the Edinburg Artery Study. Diabetes Care 2006; 29 637-42.
139. Olijhoek JK, Van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL, for the SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25:342-8.
140. Lahoz C, Garcia-Iglesias MF, Vicente I, Taboada M, Laguna F, Mostaza JM. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care 2006; 29:148-50.
141. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35:S117-31.
142. Liew YP, Bartholomew JR, Demirjian S, Michaels J, Schreiber MJ Jr. Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high risk population. Clin J Am Nephrol 2008; 3:1084-9.
143. Chou CK, Weng SW, Chang HW, Chen CY, Su SC, Liu RT. Analysis of traditional and non-traditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan. Diabetes Res Clin Pract 2008; 81:331-7.
144. Mlekusch W, Exner M, Sabeti S, Amighi J, Sclager O, Wagner O, et al Serum creatinine predicts mortality in patients with peripheral artery disease: Influence of diabetes and hypertension. Atherosclerosis 2004; 175:361-7.
145. O'Hare AM, Sidaway AN, Feinglass J, Magee Merine K, Daley J, Khuri S, et al. Influence of renal insufficiency on limb loss and mortality after initial extremity surgical revascularisation. J Vasc Surg 2004; 39:709-16.
146. DeLoach SS, Mohler ER III. Peripheral arterioal disease: A guide for nephrologists. Clin J Am Soc Nephrol 2007; 2:839-46.
147. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007; 116:85-97.
148. Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW. Hyperhomocysteinaemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am J Kidney Dis 1999; 34:669-77.
149. Samanta A, Burden AC, Jagger C. A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, UK. Diabetes Res Clin Pract 1991; 14 205-13.
150. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Eng J Med 1989; 321:1074-9.
151. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks: A population based study of potential explanatory factors. JAMA 1992; 268 3079-84.
152. Burden AC, McNally PG, Feehally J, Walls J. Increased incidence of end-stage renal failure secondary to DM in Asian ethnic groups in the United Kingdom. Diabet Med 1992; 9:641-5.
153. Jenkins C, McNary S, Carlson BA, King MG, Hossler CL, Magwood G, et al. Reducing disparities for African Americans with diabetes; progress made by the REACH 2010 Charleston and Georgetown Diabetes Coalition. Public Heath Rep 2004; 119:322-30.
154. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001; 37:1184-90.
155. Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG, et al. Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 1998; 31:28-34.
156. Pei YP, Greenwood CM, Cherry AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int 2000; 58:1293-9.
157. Salahudeen AK, Deogaygay B, Fleishmann E, Bower JD. Race-dependent survival disparity on hemodialysis: Higher serum albuminum as an independent risk factor for higher mortality in whites. Am J Kidney Dis 2000; 36:1147-54.
158. Parekh RS, Zhang L, Fivush BA, Klag MJ. Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: A sample of the US ESRD population. J Am Soc Nephrol 2005; 16:1420-6.
159. Hobbs SD, Wilmink AB, Bradbury AW. Ethnicity and peripheral arterial disease. Eur J Vasc Surg 2003; 25:505-12.
160. Robbs JV. Atherosclerotic peripheral arterial disease in blacks- an established problem. S Afr Med J 1985; 67:797-801.
161. Dardik A, Lin JW, Gordon TA, Williams GM, Perler BA. Results of elective abdominal aortic aneurysm repair in the 1990s: A population based analysis of 2335 cases. J Vasc Surg 1999; 30:985-95.
162. Markus HS, Khan U, Birns J, Evans A, Kalra L, Rudd AG, et al. Difference in stroke subtypes between Black and White patients with stroke. The South London Ethnicity and Stroke Study. Circulation 2007; 116:2157-64.
163. Deneuville M, Pierrot JM, N'Guyen RN. Particularities of peripheral arterial disease managed in vascular surgery in the French West Indies. Arch Cardiovasc Dis 2008; 101:23-9.
164. Shead GV, Oomen RM, Savarirayan SS. The pattern of non-diabetic peripheral vascular disease in South India. Br J Surg 1978; 65 49-53.
165. Jude EB, Oyibo SO, Chalmers, Boulton AJ. Peripheral arterial disease in diabetic and non-diabetic patients: A comparison of severity and outcome. Diabetes Care 2001; 24:1433-7.
166. Leggeter S, Chaturvedi N, Fuller JH, Edmonds ME. Ethnicity and risk of diabetes-related lower extremity amputation. A population-based, case-control study of African Caribbeans and Europeans in the United Kingdom. Arch Intern Med 2002; 162:73-8.